Trials / Completed
CompletedNCT00576277
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain
A Prospective, Double-Blind, Randomized, Placebo-Controlled Trial of AV411 to Assess Its Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in the Treatment of Neuropathic Pain
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Avigen · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of AV411 after single and multiple doses in patients with chronic neuropathic pain due to diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AV411 |
Timeline
- Start date
- 2006-09-01
- Completion
- 2007-11-01
- First posted
- 2007-12-19
- Last updated
- 2007-12-19
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00576277. Inclusion in this directory is not an endorsement.